Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)-Reference-Cited by-同舟云学术

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

Published:2016-05-02 Issue:6 Volume:18 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Crawford Jeffrey,Prado Carla M. M.,Johnston Mary Ann,Gralla Richard J.,Taylor Ryan P.,Hancock Michael L.,Dalton James T.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-016-0522-0.pdf

Reference61 articles.

1. Prado CM, Maia YL, Ormsbee M, Sawyer MB, Baracos VE. Assessment of nutritional status in cancer—the relationship between body composition and pharmacokinetics. Anti Cancer Agents Med Chem. 2013;13(8):1197–203.

2. Prado CM. Body composition in chemotherapy: the promising role of CT scans. Curr Opin Clin Nutr Metab Care. 2013;16(5):525–33.

3. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009;15(8):2920–6.

4. Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010;91(4):1133s–7s.

5. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ (Clinical research ed). 1997;315(7117):1219–22.

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing androgen receptor: Revolutionizing diabetes treatment in men with selective androgen receptor modulators;Medical Hypotheses;2024-09

2. Using multiple primary endpoints in clinical trials with a focus on heart failure;Global Cardiology;2024-06-28

3. Selective androgen receptor modulator abuse induced heart failure: catastrophic effects of RAD-140 (Testolone);Polish Archives of Internal Medicine;2024-06-05

4. IS SARM - Selective Androgen Receptor Modulator: A Chance for Therapeutic Approach in Muscle-Wasting Chronic Conditions?;Muscle Ligaments and Tendons Journal;2024-06

5. Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies;International Journal of Molecular Sciences;2024-05-08